Live Breaking News & Updates on Laine yonker

Stay informed with the latest breaking news from Laine yonker on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Laine yonker and stay connected to the pulse of your community

SIGA Amends International Promotion Agreement with Meridian to Enhance International Growth Opportunities of Oral TPOXX®

SIGA Amends International Promotion Agreement with Meridian to Enhance International Growth Opportunities of Oral TPOXX®
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-kingdom , Laine-yonker , Diem-nguyen , Holly-stevens , Exchange-commission , Development-authority , Nasdaq , Edison-group , Us-department-of-health , Healthcare-products-regulatory-agency , Us-department-of-defense , Meridian-medical-technologies-inc

SIGA Names Larry Miller General Counsel

SIGA Names Larry Miller General Counsel
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-kingdom , Laine-yonker , Diem-nguyen , Holly-stevens , Gotshal-manges , Larry-miller , Exchange-commission , Arnold-porter , Healtcare-products-regulatory-agency , Development-authority , Edison-group , Us-department-of-defense

SIGA Declares Special Cash Dividend of $0.60 Per Share

NEW YORK, March 12, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today ann...

United-kingdom , Laine-yonker , Diem-nguyen , Holly-stevens , Edison-group , Us-department-of-defense , Biomedical-advanced-research , Development-authority , Technologies-inc , Exchange-commission , Human-services , European-medicines-agency

SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2023

SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2023
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United-kingdom , Canada , Diem-nguyen , Holly-stevens , Laine-yonker , Administration-for-strategic-preparedness , Us-department-of-health , Response-authority , Technologies-inc , European-commission , Biomedical-advanced-research , Berry-company

Incannex Announces Positive Topline Results from Phase 2

Highlights: PsiGAD1 trial achieves primary endpoint; PsiGAD psilocybin-assisted therapy demonstrated a statistically significant HAM-A reduction of 12.8...

Melbourne , Victoria , Australia , Monash , South-australia , United-states , Joel-latham , Paul-liknaitzky , Laine-yonker , Nasdaq , Edison-group , Clinical-psychedelic-lab-at-monash-university

Biodexa Pharmaceuticals PLC: Biodexa Announces Positive Top Line Phase I Clinical Trial Results for Diffuse Midline Glioma and Provides R&D Update

Biodexa Pharmaceuticals PLC: Biodexa Announces Positive Top Line Phase I Clinical Trial Results for Diffuse Midline Glioma and Provides R&D Update
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

China , United-kingdom , Philadelphia , Pennsylvania , United-states , Dmitry-zamoryakhin , Laine-yonker , International-symposium-on-pediatric-neuro , Nasdaq , Columbia-university-irving-medical-center , Biodexa-pharmaceuticals , Exchange-commission

Biodexa Announces Positive Top Line Phase I Clinical Trial Results for Diffuse Midline Glioma and Provides R&D Update

Biodexa Announces Positive Top Line Phase I Clinical Trial Results for Diffuse Midline Glioma and Provides R&D Update
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United-kingdom , United-states , Philadelphia , Pennsylvania , Laine-yonker , Dmitry-zamoryakhin , International-symposium-on-pediatric-neuro , Nasdaq , Columbia-university-irving-medical-center , Exchange-commission , Biodexa-pharmaceuticals , Edison-group-us-investor-relations

Incannex Completes Successful Pre-IND Meeting with the FDA for CannQuit-N; a Novel Solution for Tobacco Smoking Cessation

MELBOURNE, Australia and NEW YORK, Feb. 16, 2024 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL), (Incannex or the Company), a leading cannabinoid and psychedelic medicine biotechnology company, is pleased to announce the successful completion of a pre-IND (Investigational New Drug) meeting with the U.S. Food and Drug Administration (FDA) regarding the development of CannQuit-N for tobacco smoking cessation and control of relapse. The pre-IND teleconference included representatives f

United-states , Melbourne , Victoria , Australia , Laine-yonker , Joel-latham , Drug-administration , Edison-group , Incannex-healthcare-inc , Nasdaq , Investigational-new-drug , Incannex-board

Biodexa Reports 12 Month Survival in MAGIC-G1 Study of MTX110 in Recurrent Glioblastoma Patients

Biodexa Reports 12 Month Survival in MAGIC-G1 Study of MTX110 in Recurrent Glioblastoma Patients
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United-states , United-kingdom , Laine-yonker , Exchange-commission , Edison-group-us-investor-relations , Nasdaq , Biodexa-pharmaceuticals , Duke-cancer-institute , Company-nasdaq , Baptist-md-anderson-cancer-center , Recurrent-glioblastoma , Glioblastoma-multiforme